The power of precision.
For every oncologist.
Today.

Every cancer patient deserves the right treatment
for their individual form of cancer.

When is IndiTreat appropriate? (For clinicians)

For over 2 decades, testing cancer treatments on microtumors rather than on the patient has been on the horizon. With IndiTreat®, 2cureX makes microtumor testing an operational reality to serve you and your cancer clinic.

Is IndiTreat for you? (For patients)

IndiTreat tests determine the sensitivity to different drug regimens for certain types of metastic colorectral cancer. Ask your doctor if it is possible to consider IndiTreat for your cancer.

Key benefits of IndiTreat

  • Tumor resistance
    Predict tumor resistance and sensitivity to cancer drugs
  • Right cancer treatment
    Select the most appropriate treatment, in accordance with guidelines or off-label
  • Better patient outcome
    Improve patient quality of life through in vitro testing of drug efficacy on the individual patient

Read more

2cureX - Product box
  • Help chemo-naïve CRC patients
    Identify the most effective treatment in chemo-naïve colorectal cancer patients
  • Help late-stage CRC patients
    Identify the most effective treatment in late-stage colorectal cancer patients
  • Functional precision medicine
    Complement the genomic characterisation of tumours with functional data on resistance and sensitivity to drugs

Latest press and news start

Stay updated with our news and press releases

Get notified on mail, when news or press releases are posted on our website

Get notified on mail, when news or press releases are posted on our website

Urgent medical need in colorectal cancer